CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Total revenues	$ 10,596,428	$ 7,767,189	$ 27,415,843	$ 20,697,907
Cost of revenues	4,847,780	3,797,919	11,971,135	10,744,264
Gross profit	5,748,648	3,969,270	15,444,708	9,953,643
Operating expenses
Selling, general and administrative	4,386,757	3,618,071	13,283,645	10,957,619
Depreciation and amortization	738,883	628,324	2,131,234	1,838,354
Total operating expenses	5,125,640	4,246,395	15,414,879	12,795,973
Income (loss) from operations	623,008	(277,125)	29,829	(2,842,330)
Other income
Interest income, net	265,284	6,119	349,847	18,230
Income (loss) before income tax provision	888,292	(271,006)	379,676	(2,824,100)
Income tax provision	36,183	0	64,996	2,400
Net income (loss)	$ 852,109	$ (271,006)	$ 314,680	$ (2,826,500)
Basic	$ 0.02	$ (0.01)	$ 0.01	$ (0.06)
Diluted	$ 0.02	$ (0.01)	$ 0.01	$ (0.06)
Weighted average common shares
Basic	52,142,225	51,154,725	51,968,496	50,754,652
Diluted	53,365,025	51,154,725	52,676,707	50,754,652
Plasma Industry [Member]
Revenues
Total revenues	$ 9,829,811	$ 7,035,546	$ 25,030,376	$ 18,366,010
Pharmaceutical industry [Member]
Revenues
Total revenues	693,353	660,331	2,273,232	2,184,198
Other Revenue [Member]
Revenues
Total revenues	$ 73,264	$ 71,312	$ 112,235	$ 147,699